Highlights

  • Phoslock Environmental Technologies shares declined 9.09% to AUD 0.010 on 23 April 2026, following the release of its March quarterly.
  • Cash position stood at AUD 4.3 million on 31 March 2026, down AUD 892,000 during the quarter.
  • Net operating cash outflow improved to AUD 776,000 compared to AUD 953,000 in the prior corresponding period.
  • Sales receipts declined to AUD 466,000, while cost reductions partially offset lower inflows.
  • Production resumed in January, with operational stability improving toward the end of the quarter.

Phoslock Environmental Technologies Ltd (ASX:PET) shares moved lower by 9.09% to AUD 0.010 during the afternoon trading session on 23 April 2026, following the release of its March 2026 quarterly activities report and Appendix 4C. The decline comes as the company reported a combination of operational progress alongside ongoing financial outflows, presenting a mixed picture for investors.

The latest update highlighted improvements in certain areas such as reduced operating cash deficits and operational progress at its manufacturing facility, while also reflecting lower sales receipts and a decline in overall cash reserves during the quarter.

Company Overview

Phoslock Environmental Technologies Ltd operates in the environmental solutions sector, focusing on water treatment technologies aimed at improving water quality across lakes, rivers, canals, and drinking water reservoirs. The company’s primary product, Phoslock®, is designed to bind excess phosphorus in water bodies, thereby addressing issues related to water pollution and ecosystem degradation.

The company maintains a global footprint, with headquarters in Sydney and operational presence across China, Europe, and the United States. Through a network of distributors, licensees, and agents, Phoslock continues to target international markets where water remediation solutions are required.

Cash Position and Quarterly Financial Movement

At the end of the March 2026 quarter, the company reported a cash balance of AUD 4.3 million, representing a decline of AUD 892,000 compared to the previous quarter. This movement reflects ongoing operational expenditures and the broader cash flow dynamics during the period.

Net cash used in operating activities amounted to AUD 776,000, showing an improvement from the AUD 953,000 outflow recorded in the March quarter of 2025. The reduction in the operating deficit was primarily driven by a larger decrease in operating expenses relative to the decline in sales receipts.

Sales receipts for the quarter totalled AUD 466,000, down from prior periods, indicating variability in revenue inflows. At the same time, net operating outlays stood at AUD 1.242 million, which included AUD 282,000 in legal-related expenses. These legal costs were largely offset by reimbursements of AUD 274,000 received from AXA Insurance.

From a broader cash flow perspective, total net cash outflow for the quarter was AUD 792,000, compared to a positive inflow in the December quarter. Foreign exchange movements also impacted the cash position, reducing it by AUD 100,000 during the period.

Quarterly Cash Flow Trends Reflect Volatility

The company’s reported quarterly data underscores fluctuations in financial performance across recent periods. Sales receipts have varied, ranging from AUD 562,000 to AUD 1.095 million over the past five quarters, before declining to AUD 466,000 in the March 2026 quarter.

Similarly, operating cash flows have shifted between negative and positive territory, including a brief positive inflow of AUD 129,000 in the December 2025 quarter, followed by a return to a deficit in the latest reporting period.

The company noted that such quarterly figures can be volatile and should not be directly extrapolated to longer-term trends, indicating that performance may vary across reporting periods.

Operational Progress and Production Developments

On the operational front, the company reported progress across several areas during the quarter. Sales volumes reached 385 tonnes, broadly in line with the 381 tonnes recorded in the same period of the previous year.

Geographically, Brazil accounted for the majority of sales at 60%, followed by Europe at 24%, Australia at 13%, and the United States at 3%. This distribution highlights the company’s continued reliance on international markets, particularly in South America and Europe.

Production during the quarter totalled 356 tonnes. The company’s manufacturing facility resumed operations on 5 January 2026 after being inactive for an extended period. As expected, the restart phase encountered equipment-related issues early in the quarter, affecting production consistency.

The plant operated for 37 out of 62 available weekdays, with downtime attributed to statutory holidays and maintenance requirements. However, operational performance improved over time, with the facility running every weekday during the final three weeks of March and approaching its current capacity of approximately 14.7 tonnes per day.

Inventory levels as of 31 March 2026 stood at 1,151 tonnes, including 466 tonnes located in China.

Research and Development Activities Continue

The company also reported ongoing research and development efforts, particularly in China. During the quarter, a product containing 10% lanthanum content was developed, demonstrating favourable phosphorus-binding characteristics and free lanthanum properties.

Preparations are underway for a patent application related to this development. In addition, the company is planning to produce bulk samples for further testing, including third-party laboratory analysis and in-lake trials.

These activities reflect continued focus on product development and potential enhancements to existing water treatment solutions.

Legal Matters and Corporate Developments

Phoslock continues to address legacy legal matters, including a potential class action initiated by the Banton Group on behalf of certain shareholders. The matter remains in the discovery phase, with mediation currently scheduled to commence on 11 June 2026.

The company indicated that it cannot predict the outcome of these proceedings but confirmed its intention to comply with regulatory obligations and defend its position in relation to the claims.

In line with regulatory disclosures, payments to related parties during the quarter totalled AUD 37,000, primarily relating to directors’ fees, including superannuation for non-executive directors.

Liquidity Position and Funding Outlook

Based on reported figures, the company has an estimated six quarters of funding available, calculated using its current cash balance and operating cash outflows. This suggests that, under current conditions, the company maintains a level of liquidity to support ongoing operations in the near term.

No financing inflows or borrowings were reported during the quarter, and the company does not currently have additional financing facilities in place.

What This Means for Investors?

The March 2026 quarterly update reflects a combination of operational progress and ongoing financial challenges. While the company reported improvements in operating cash flow deficits and production stability toward the end of the quarter, lower sales receipts and a declining cash balance appear to have influenced investor sentiment.

Today’s share price decline suggests that the market is weighing these mixed signals, particularly the balance between operational improvements and continued cash outflows. The progress in restarting the manufacturing facility, ongoing R&D initiatives, and stable sales volumes may be areas of focus moving forward, alongside cash flow management and legal developments.

As the company continues into the next quarter, investors are likely to monitor changes in revenue trends, operational efficiency, and developments related to its legal matters and product pipeline.